Work

Adaptive dose optimization trial of stereotactic body radiation therapy (SBRT) with or without GC4419 (avasopasem manganese) in pancreatic cancer.

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.15_suppl.tps4670

Authors: Elizabeth Charlotte Moser, Sarah E. Hoffe, Jessica Frakes, Todd Anthony Aguilera, Mona Karim, Lauren Elizabeth Colbert, Shalini Moningi, Ching-Wei David Tzeng, Peter F. Thall, Shubham Pant, Manoop S. Bhutani, Melissa Brookes, Jon Holmlund, Joseph M. Herman, Cullen M. Taniguchi

Institutions: Galera Therapeutics, Inc. (United States), Moffitt Cancer Center, The University of Texas Southwestern Medical Center, Morristown Medical Center, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3031398566

Cites:

Cited by: 2

Related to: 10